Related Experiment Video
Updated: Aug 14, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
Stroke and brain atrophy in chronic Chagas disease patients: A new theory proposition
1MD, PhD, Associate Professor, Coordinator of the Stroke Clinic, Federal University of Bahia. Head of Neurology Service and Neurocritical Care Unit, Hospital Espanhol in Salvador, BA, Brazil.
Insights
Chagas disease (CD) causes brain damage through heart issues and inflammation. New evidence suggests chronic inflammation, not just heart problems, leads to stroke and brain atrophy in CD patients.
Area of Science:
- Neurology
- Infectious Diseases
- Cardiology
Background:
- Chagas disease (CD) is a significant cause of stroke and cardiomyopathy globally.
- Current understanding attributes CD-related brain damage solely to cardiac complications like cardioembolism.
- However, stroke and brain atrophy occur in CD patients irrespective of cardiac disease severity.
Purpose of the Study:
- To present evidence for a new theory on Chagas disease-related brain damage.
- To explore the role of chronic inflammation in CD-induced neurological complications.
- To discuss potential mechanistically-based treatments for Chagas disease.
Main Methods:
- Review and synthesis of existing evidence.
- Analysis of pathological mechanisms linking inflammation to neurological damage.
- Consideration of therapeutic targets.
Main Results:
- Chronic inflammation against T. cruzi may independently cause endothelial damage and platelet activation.
- Inflammation can accelerate atherosclerosis and apoptosis, contributing to stroke and brain atrophy.
- These inflammatory pathways offer an alternative explanation for neurological damage in Chagas disease.
Conclusions:
- Chagas disease may cause brain damage through direct inflammatory mechanisms, not solely cardiac issues.
- Targeting chronic inflammation presents a novel therapeutic strategy for preventing stroke and brain atrophy in CD.
- Further research is needed to validate these inflammatory pathways and develop targeted treatments.
Abstract:
Chagas disease (CD) remains a major cause of cardiomyopathy and stroke in developing countries. Brain damage in CD has been attributed exclusively to the effects of structural heart disease on the brain, including cardioembolism and low cardiac output symptoms. However, CD patients also develop stroke and brain atrophy independently of cardiac disease severity. Chronic inflammation directed against T. cruzi may act as a trigger for endothelial damage, platelet activation, acceleration of atherosclerosis and apoptosis, all of which lead to stroke and brain atrophy. In the present article, evidence supporting this new theory is presented, along with considerations towards mechanistically-based targeted treatment.
Related Concept Videos
American Trypanosomiasis
Ischemic Stroke ll: Pathophysiology
Alzheimer Disease ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology

